Is Ketamine Therapy FDA Approved?

02/25/2026

7 minute read

Key Takeaways:

Ketamine vs. Spravato: Ketamine is FDA-approved as an anesthetic, not for mental health conditions. Spravato (esketamine) is FDA-approved for specific depression types under strict safety protocols (REMS).
Off-Label Use: Many clinics offer ketamine therapy off-label for depression, anxiety, and PTSD, but this is not FDA-approved and varies in safety and oversight.
Safety Concerns: Ketamine is a controlled substance with misuse potential. Proper medical screening, monitoring, and clear protocols are essential for safe treatment.
Evaluating Providers: Look for clinics with transparent safety standards, medical credentials, and clear protocols. Avoid those making unrealistic claims or pushing take-home products.

Question:

Is ketamine therapy FDA-approved, and can it help with treatment-resistant depression?

Answer:

Ketamine therapy is gaining attention for mental health treatment, but understanding its FDA approval status is crucial. Ketamine is approved only as an anesthetic, while Spravato (esketamine) is FDA-approved for specific depression types under strict safety measures. Off-label ketamine therapy is common but lacks FDA approval, making provider evaluation critical. Safety concerns include misuse potential, emphasizing the need for medical screening and monitoring. To ensure safe and effective care, choose providers with clear protocols and avoid those making exaggerated claims.

Advertisements and headlines about ketamine therapy are everywhere. Clinics promote their use for depression, anxiety, and PTSD, while telehealth companies offer at-home options. With so much information available, it’s easy to get confused about what is safe, effective, and officially approved. The language used by the U.S. Food and Drug Administration (FDA) is very specific, and it often differs from marketing claims.

Understanding this distinction is crucial for making an informed and safe decision about your mental health care. This post will clarify the facts. We will cover what is FDA-approved, what “off-label” use means, how a safety program called REMS works, and how you can evaluate a provider to ensure you receive responsible care.

Not sure what to trust—or worried about the potential for misuse? Talk with Footprints to Recovery for a confidential assessment and guidance.

The Short Version: A Quick Look at Approval

Ketamine (brand name KETALAR) is FDA-approved, but only as a general anesthetic for medical procedures. It is not FDA-approved as a treatment for depression, anxiety, PTSD, or any other psychiatric disorder.
The FDA has specifically stated that ketamine is not approved for any psychiatric condition, and it has issued warnings about the safety of compounded ketamine products (custom-made formulations).
Spravato® (esketamine) is a nasal spray that is FDA-approved for specific types of depression. It is chemically related to ketamine but is a different drug. Its use is strictly controlled under a mandatory safety program.

“Ketamine Therapy” vs. “Spravato”: Defining the Terms

When you hear about ketamine for depressive disorders, it’s important to know exactly what product and service is being discussed. The terms are often used interchangeably, but they refer to very different things.

What People Mean by “Ketamine Therapy”

This term usually refers to the off-label use of ketamine to treat mental health conditions. “Off-label” means a doctor prescribes a drug for a condition other than what the FDA officially approved it for. This can be delivered in several ways:

Intravenous (IV) infusions
Intramuscular (IM) injections
Oral or sublingual (under the tongue) lozenges
Compounded nasal sprays

These treatments are often paired with psychotherapy or monitoring, which is why the word “therapy” is used. However, the protocols are not standardized across all clinics.

What Spravato Is

Spravato is the brand name for esketamine, a prescription nasal spray. Unlike general ketamine, Spravato has gone through the rigorous FDA-approval process specifically for:

Treatment-Resistant Depression (TRD) in adults.
Major Depressive Disorder (MDD) with acute suicidal ideation or behavior in adults.

It is never a take-home prescription. Due to its risks, Spravato must be administered in a certified healthcare setting where the patient can be monitored for at least two hours after dosing.

What Is FDA-Approved About Ketamine?

Ketamine hydrochloride (brand name KETALAR) is an injectable drug that is FDA-approved as a general anesthetic. Its official label indicates its use for sedation during short medical procedures that don’t require skeletal muscle relaxation.

FDA approval is tied to very specific factors: the medical condition (indication), the dosage, the route of administration (e.g., injection), and the setting. Ketamine’s approval is strictly for anesthesia in a controlled medical environment, not for psychiatric use.

Understanding “Off-Label” Use and FDA Warnings

Since ketamine is not FDA-approved for mental health, how can clinics offer it?

Ketamine for Depression, Anxiety, and PTSD = Off-Label

It is legal for licensed clinicians to prescribe a drug for an unapproved use when they judge that it is medically appropriate for their patient. This is known as “off-label” prescribing. Many clinics provide ketamine for psychiatric conditions this way. While this practice is legally permissible, it is not the same as having FDA approval, which guarantees a drug has been proven safe and effective for that specific use.

The FDA’s Stance on Compounded Ketamine

Compounded drugs are custom-made by a pharmacy for an individual patient, which means they do not have FDA approval. The FDA has released specific warnings about compounded ketamine products, like lozenges or nasal sprays, citing concerns about their safety and effectiveness for psychiatric conditions.

This leads to a critical question: If a treatment is being used off-label, how do you know it’s being administered safely?

Why Spravato Is Treated Differently: The REMS Program

The reason Spravato has a strict administration process is because of its FDA-mandated Risk Evaluation and Mitigation Strategy (REMS).

What REMS Means in Plain English

A REMS is a safety program that the FDA requires for certain medications with serious safety concerns. The goal is to ensure the benefits of the medication outweigh its risks. For Spravato, the REMS requires that both the prescribing doctor and the facility where it is administered are certified. Patients must be enrolled in the program and monitored by a healthcare provider during and after each treatment.

Why the Monitoring Requirement Exists

Spravato’s label carries serious warnings, including risks of sedation, dissociation (an “out-of-body” experience), and potential for abuse and misuse. The REMS program ensures that any adverse effects are managed immediately in a professional setting. This is a key difference from take-home compounded ketamine products. If a product claims to be “Spravato-like at home,” it’s important to understand it lacks the required FDA oversight and safety monitoring.

Safety, Side Effects, and Misuse Risk

Ketamine is classified as a Schedule III controlled substance due to its potential for abuse and dependence. This makes professional screening and supervision essential. When administered improperly or used without medical oversight, ketamine can become problematic. Warning signs of misuse or addiction include:

Developing a tolerance and needing more to get the same effect.
Spending a significant amount of time obtaining and using the drug.
Cravings or a strong desire to use ketamine.
Continuing use despite negative consequences on health or relationships.

If these signs sound familiar, seeking help is a critical step toward recovery.

How to Evaluate a Ketamine Provider Responsibly

If you are considering ketamine therapy, it is vital to vet the provider carefully. Use this checklist to assess their commitment to safety and medical standards.

Safety and Medical Standards

Comprehensive Medical Screening: Does the provider conduct a thorough evaluation of your physical and mental health history, including cardiac/blood pressure issues, substance use history, and potential medication interactions?
On-Site Monitoring: Is a qualified medical professional present to monitor you during and after the session? Do they have emergency preparedness plans?
Clear Protocols: Is there a clear dosing protocol and follow-up plan? A responsible provider should be transparent about their treatment approach.

Marketing Red Flags

Guarantees of a “Cure”: Be wary of clinics promising miraculous results or using language like “miracle cure.”
Vague Credentials: Look for providers with clear and relevant medical credentials in psychiatry or anesthesiology.
Pushing Take-Home Products: Be cautious of any provider who pushes take-home compounded products without a clear and robust plan for oversight and monitoring.

Always ask for written protocols and informed consent documents that clearly outline the risks and benefits.

Cost and Insurance Expectations

The cost of treatment can vary significantly based on the type of therapy. You can verify your insurance prior to treatment to ensure a smooth admissions process.

Spravato: Because it is FDA-approved and follows a standardized process, Spravato often has more established pathways for insurance coverage. However, policies vary, and pre-authorization is usually required.
Off-Label Ketamine: These treatments (like IV infusions) are often self-pay. The cost can range from several hundred to over a thousand dollars per session.

Who Should Be Extra Cautious?

Certain individuals should be particularly cautious when considering ketamine. Integrated care that addresses both mental health and substance use is essential for those with:

A history of substance use disorder: The abuse potential of ketamine requires careful consideration for anyone with a history of addiction.
Co-occurring mental health diagnoses: Individuals with complex conditions or those experiencing suicidal thoughts need close, integrated clinical support.

If you are balancing depression treatment options and have concerns about substance use, an evaluation for dual diagnosis is the safest approach. Footprints to Recovery can help you sort through the options and find the safest path forward.

Conclusion: Your Safest Next Step

Navigating the world of ketamine therapy requires you to be an informed advocate for your own health. Let’s recap the key distinctions:

FDA-approved ketamine is labeled for use as an anesthetic only.
Ketamine “therapy” for psychiatric conditions is an off-label use. Compounded forms carry additional FDA safety warnings.
Spravato (esketamine) is FDA-approved for specific types of depression and must be administered under a strict REMS safety program. Our depression treatment center in Elgin, IL, currently offers Spravato for depression.

Your mental health journey deserves a clinically supervised and individualized plan. This is especially true if you have a history of substance use. By prioritizing safety, asking the right questions, and seeking comprehensive care, you can make a choice that truly supports your well-being.